Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells
Clinical trial NCT03236129 · UNKNOWN
Trial details
- NCT number
- NCT03236129
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-22
- Primary completion
- 2025-02-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.